Sfoglia per Autore
PIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo
2017-01-01 Cafforio, Paola; Viggiano, Luigi; Mannavola, Francesco; Pellè, Eleonora; Caporusso, Concetta; Maiorano, Eugenio; Felici, Claudia; Silvestris, Francesco
The management of refractory carcinoid syndrome: challenges and opportunities ahead
2018-01-01 Cives, Mauro; Pelle', Eleonora; Silvestris, Franco
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
2018-01-01 Palmirotta, Raffaele; Lovero, Domenica; Cafforio, Paola; Felici, Claudia; Mannavola, Francesco; Pellè, Eleonora; Quaresmini, Davide; Tucci, Marco Gaetano; Silvestris, Franco
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
2019-01-01 Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F.
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
2019-01-01 Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F.
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
2020-01-01 Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice
2020-01-01 Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability
2021-01-01 Lauricella, E.; Cives, M.; Bracigliano, A.; Clemente, O.; Felici, V.; Lippolis, R.; Amoruso, B.; Pelle', E.; Mandriani, B.; Esposto, C.; Forte, C.; Perri, F.; Porta, C.; Tafuto, S.
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives
2021-01-01 Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C.
1101MO Development of CAR T-cells for future treatment of NETs
2021-01-01 Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| PIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo | 1-gen-2017 | Cafforio, Paola; Viggiano, Luigi; Mannavola, Francesco; Pellè, Eleonora; Caporusso, Concetta; Maiorano, Eugenio; Felici, Claudia; Silvestris, Francesco | |
| The management of refractory carcinoid syndrome: challenges and opportunities ahead | 1-gen-2018 | Cives, Mauro; Pelle', Eleonora; Silvestris, Franco | |
| Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology | 1-gen-2018 | Palmirotta, Raffaele; Lovero, Domenica; Cafforio, Paola; Felici, Claudia; Mannavola, Francesco; Pellè, Eleonora; Quaresmini, Davide; Tucci, Marco Gaetano; Silvestris, Franco | |
| DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors | 1-gen-2019 | Cives, M.; Partelli, S.; Palmirotta, R.; Lovero, D.; Mandriani, B.; Quaresmini, D.; Pelle', E.; Andreasi, V.; Castelli, P.; Strosberg, J.; Zamboni, G.; Falconi, M.; Silvestris, F. | |
| The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. | 1-gen-2019 | Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F. | |
| Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors | 1-gen-2020 | Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan | |
| Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice | 1-gen-2020 | Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F | |
| The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability | 1-gen-2021 | Lauricella, E.; Cives, M.; Bracigliano, A.; Clemente, O.; Felici, V.; Lippolis, R.; Amoruso, B.; Pelle', E.; Mandriani, B.; Esposto, C.; Forte, C.; Perri, F.; Porta, C.; Tafuto, S. | |
| Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives | 1-gen-2021 | Mandriani, B.; Pelle', E.; Pezzicoli, G.; Strosberg, J.; Abate-Daga, D.; Guarini, A.; Cives, M.; Porta, C. | |
| 1101MO Development of CAR T-cells for future treatment of NETs | 1-gen-2021 | Mandriani, B.; Pelle', E.; Mannavola, F.; Ingravallo, G.; Cazzato, G.; Ramello, M. C.; Porta, C. G.; Strosberg, J. R.; Abate-Daga, D.; Cives, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile